News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
Filament Announces Shareholder Approval of Amalgamation and Closing of Private Placement Financing
Filament Health
New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed
Core One Labs Inc.
Core One Labs Retains Canada’s Highest-Ranked IP Law Firm to Assist With Patent Filings
Core One Labs Inc.
Dr. Carl Laird Birmingham | Advisory board & Consultant, NeonMind Biosciences
NeonMind Biosciences Inc.
atai Life Sciences Announces Pricing of Upsized Initial Public Offering
ATAI Life Sciences
Diamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial
Diamond Therapeutics
Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences and Silo Wellness Announces Psychedelics Genetic Test Kit Partnership
Entheon Biomedical
Silo Wellness
Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression
Braxia Scientific Corp.
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics
Revive Therapeutics
Novamind Announces US$1,000,000 Strategic Investment in Stealth Mode Drug Development Company
Novamind Inc.
MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board
Mind Medicine (MindMed)
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET
Field Trip Health
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.